Category: MS Treatments

Fumarates Lead to Lower Infection-Related Healthcare Resource Utilization Relative to Anti-CD20s

May 30, 2025 Key Takeaways A study reveals long-term fumarate therapy significantly reduces infection-related healthcare utilization in multiple sclerosis patients…

Stuart Schlossman

MS Therapy Cladribine Remains Effective in Patients With Suboptimal Response to Prior Injectable DMT

May 14, 2025 Cladribine shows promising results in reducing relapse rates for patients with relapsing multiple sclerosis after inadequate response…

Stuart Schlossman

Rebound Effect Not Observed With Multiple Sclerosis Therapy Ozanimod

Author: Marco Meglio – May 29, 2025 Key Takeaways A recent large cohort analysis of global MS registry data reported…

Stuart Schlossman